SBC Medical Group Holdings Incorporated Capital Expenditures
SBC Medical Group Holdings Incorporated (SBC) reported Capital Expenditures of $209.39 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-13
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $84.40K, a 72.48% decline year-over-year.
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $125.00K, a 50.74% decline year-over-year.
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $797.53K, a 35.09% increase year-over-year.
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $43.05K, a 89.47% decline year-over-year.
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for fiscal 2025 was $1.40M, a 45.37% decline from fiscal 2024.
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for fiscal 2024 was $2.56M, a 69.98% decline from fiscal 2023.
- SBC Medical Group Holdings Incorporated payments to acquire property, plant, and equipment for fiscal 2023 was $8.54M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2026-06-30 | $84.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $209.39K 10-Q · filed 2026-08-13 | $1.01M derived: sum of 3 quarters · filed 2026-08-13 | $1.05M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $125.00K 10-Q · filed 2026-05-14 | $922.52K derived: sum of 2 quarters · filed 2026-05-14 | $965.58K derived: sum of 3 quarters · filed 2026-05-14 | $1.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $797.53K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $840.58K derived: sum of 2 quarters · filed 2026-03-27 | $1.15M derived: sum of 3 quarters · filed 2026-08-13 | $1.40M 10-K · filed 2026-03-27 |
| 2025-09-30 | $43.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $349.76K derived: sum of 2 quarters · filed 2026-08-13 | $603.48K 10-Q · filed 2025-11-14 | $1.19M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $306.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $560.43K 10-Q · filed 2026-08-13 | $1.15M derived: sum of 3 quarters · filed 2026-08-13 | $1.56M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $253.72K 10-Q · filed 2026-05-14 | $844.08K derived: sum of 2 quarters · filed 2026-05-14 | $1.25M derived: sum of 3 quarters · filed 2026-05-14 | $2.12M derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $590.36K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $999.31K derived: sum of 2 quarters · filed 2026-03-27 | $1.86M derived: sum of 3 quarters · filed 2026-03-27 | $2.56M 10-K · filed 2026-03-27 |
| 2024-09-30 | $408.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.27M derived: sum of 2 quarters · filed 2025-11-14 | $1.97M 10-Q · filed 2025-11-14 | $8.22M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $863.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $1.57M 10-Q · filed 2025-08-13 | $7.81M derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $702.28K 10-Q · filed 2025-05-15 | $6.95M derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $8.54M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | $2.30M 10-Q · filed 2024-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |